AMARIN CORP PLC (17)
Browse by Contract Category
Contracts
-
Online Office Renewal Agreement dated as of September 14, 2020, by and between Amarin Pharmaceuticals Ireland Limited and Regus CME Ireland Limited
(Filed With SEC on November 5, 2020)
-
Form of Incentive Stock Option Award Agreement
(Filed With SEC on November 5, 2020)
-
Form of Deferred Restricted Stock Unit for Non-Employee Director Award Agreement
(Filed With SEC on November 5, 2020)
-
Sixth Amendment to Lease Agreement, dated April 1, 2019, by and between Amarin Pharma, Inc. and Bedminster 2 Funding, LLC
(Filed With SEC on July 31, 2019)
-
Office Service Agreement dated as of April 12, 2019 by and between Amarin Pharmaceuticals Ireland Limited and Regus CME Ireland Ltd
(Filed With SEC on July 31, 2019)
-
Online Office Renewal Agreement dated as of October 1, 2020, by and between Amarin Pharmaceuticals Ireland Limited and Regus CME Ireland Limited
(Filed With SEC on November 5, 2020)
-
Form of Non-Qualified Stock Option for Non-Employee Director Award Agreement
(Filed With SEC on November 5, 2020)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on November 5, 2020)
-
Form of Non-Qualified Stock Option Award Agreement
(Filed With SEC on November 5, 2020)
-
Amarin Corporation plc 2020 Stock Incentive Plan
(Filed With SEC on July 14, 2020)
-
Online Office Renewal Agreement dated as of February 1, 2020, by and between Amarin Pharmaceuticals Ireland Limited and Regus CME Ireland Limited
(Filed With SEC on April 30, 2020)
-
Description of Registrants Securities
(Filed With SEC on February 25, 2020)
-
Office Number
(Filed With SEC on July 31, 2019)
-
Online Office Agreement dated as of April 12, 2019 by and between Amarin Pharmaceuticals Ireland Limited and Regus CME Ireland Limited
(Filed With SEC on July 31, 2019)
-
Underwriting Agreement, dated as of July 18. 2019
(Filed With SEC on July 24, 2019)
-
Employment Agreement dated April 20, 2018 with Aaron Berg
(Filed With SEC on May 1, 2019)
-
Lease Agreement, dated February 5, 2019, by and between 440 Route 22 LLC and Amarin Pharma, Inc
(Filed With SEC on February 27, 2019)
